Home/Filings/4/0001209191-20-052044
4//SEC Filing

Lingnau Lutz 4

Accession 0001209191-20-052044

CIK 0000906709other

Filed

Sep 23, 8:00 PM ET

Accepted

Sep 24, 9:39 PM ET

Size

7.5 KB

Accession

0001209191-20-052044

Insider Transaction Report

Form 4
Period: 2020-09-22
Lingnau Lutz
Director
Transactions
  • Award

    Stock Option

    2020-09-22+18,20018,200 total
    Exercise: $18.91Exp: 2028-09-21Common Stock (18,200 underlying)
  • Award

    Common Stock

    2020-09-22+9,10035,800 total
Footnotes (3)
  • [F1]This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.
  • [F2]This restricted stock unit award vests in full, one year following September 22, 2020.
  • [F3]This stock option vests in equal monthly installments over the one-year period beginning on September 22, 2020.

Issuer

NEKTAR THERAPEUTICS

CIK 0000906709

Entity typeother

Related Parties

1
  • filerCIK 0001354179

Filing Metadata

Form type
4
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 9:39 PM ET
Size
7.5 KB